-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$8.5059.77% Upside
Cytek Biosciences, Inc. Frequently Asked Questions
-
What analysts cover Cytek Biosciences, Inc.?
Cytek Biosciences, Inc. has been rated by research analysts at Piper Sandler in the past 90 days.